Sofosbuvir with Velpatasvir in Treatment-Naive Noncirrhotic Patients with Genotype 1 to 6 Hepatitis C Virus Infection

Gregory T. Everson,William Towner,Mitchell Davis,David Wyles,Ronald Nahass,Paul J. Thuluvath,K. Peter Etzkorn,Federico Hinestrosa,Myron J. Tong,Mordechai Rabinovitz,John McNally,Diana M. Brainard,Lingling Han,Brian Doehle,John G. McHutchison,Timothy R. Morgan,Raymond T. Chung,Tram T. Tran

Annals of internal medicine（2015）

引用 105|浏览0

暂无评分

摘要

Pangenotypic treatments for HCV infection would be useful worldwide. In a phase 2 trial, treatment with sofosbuvir plus velpatasvir resulted in high sustained virologic response at 12 weeks in pati...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要